Concepts (64)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Testing | 4 | 2024 | 1004 | 0.360 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 141 | 0.250 |
Why?
|
| Chromothripsis | 1 | 2025 | 8 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2025 | 92 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2025 | 119 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2024 | 59 | 0.220 |
Why?
|
| Brain Abscess | 1 | 2024 | 57 | 0.220 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2024 | 151 | 0.220 |
Why?
|
| Hemiplegia | 1 | 2023 | 42 | 0.210 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 23 | 0.210 |
Why?
|
| Retinitis Pigmentosa | 1 | 2024 | 84 | 0.210 |
Why?
|
| Neutropenia | 1 | 2024 | 200 | 0.200 |
Why?
|
| Scimitar Syndrome | 1 | 2023 | 52 | 0.200 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 141 | 0.200 |
Why?
|
| Exons | 1 | 2025 | 796 | 0.200 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2021 | 7 | 0.190 |
Why?
|
| Galactosemias | 1 | 2021 | 14 | 0.190 |
Why?
|
| Haploinsufficiency | 1 | 2023 | 257 | 0.190 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2021 | 45 | 0.180 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 943 | 0.160 |
Why?
|
| Repressor Proteins | 1 | 2024 | 820 | 0.160 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 869 | 0.160 |
Why?
|
| Abnormalities, Multiple | 1 | 2023 | 964 | 0.140 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1817 | 0.090 |
Why?
|
| Chromosome Deletion | 2 | 2025 | 647 | 0.090 |
Why?
|
| Genomics | 2 | 2024 | 1489 | 0.060 |
Why?
|
| MEF2 Transcription Factors | 1 | 2025 | 42 | 0.060 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 16 | 0.060 |
Why?
|
| Genes, X-Linked | 1 | 2024 | 59 | 0.060 |
Why?
|
| Humans | 9 | 2025 | 124307 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2024 | 124 | 0.050 |
Why?
|
| Genetics, Medical | 1 | 2024 | 117 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2023 | 51 | 0.050 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2023 | 8 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 90 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2023 | 25 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2025 | 764 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 100 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2024 | 219 | 0.050 |
Why?
|
| Glycolipids | 1 | 2021 | 32 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2025 | 1017 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 550 | 0.050 |
Why?
|
| Female | 5 | 2025 | 66236 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2021 | 141 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 577 | 0.040 |
Why?
|
| Infant | 2 | 2024 | 12473 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1042 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2025 | 14042 | 0.040 |
Why?
|
| Mutation | 2 | 2023 | 5807 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 605 | 0.040 |
Why?
|
| Male | 4 | 2024 | 60964 | 0.040 |
Why?
|
| Genome, Human | 1 | 2025 | 1273 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2024 | 1492 | 0.040 |
Why?
|
| Adolescent | 2 | 2024 | 19300 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4731 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 26451 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3138 | 0.030 |
Why?
|
| Child | 2 | 2024 | 24435 | 0.030 |
Why?
|
| Adult | 2 | 2024 | 29385 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4256 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 8974 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 17732 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 19481 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 34153 | 0.010 |
Why?
|